Ferinject® 500 mg (50 mg iron/mL)
Ferinject 500 mg contains 500 mg of iron as ferric carboxymaltose.
Ferinject is indicated for the treatment of iron deficiency when:
– oral iron preparations are ineffective.
– oral iron preparations cannot be used.
– there is a clinical need to deliver iron rapidly.
The diagnosis of iron deficiency must be based on laboratory tests.
Monitor carefully patients for signs and symptoms of hypersensitivity reactions during and following
each administration of Ferinject.
The posology of Ferinject follows a stepwise approach:
[1] determination of the individual iron need,
[2] calculation and administration of the iron dose(s), and
[3] post-iron repletion assessments (see Leaflet for the detail).
Ferinject must only be administered by the intravenous route:
Ferinject must only be diluted in sterile 0.9% m/V sodium chloride solution, should not be diluted to concentrations less than 2 mg iron/mL (not including the volume of the ferric carboxymaltose solution).
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Headache, dizziness, feeling hot (flushing), high blood pressure, nausea and injection/infusion site reactions
There is limited data from the use of Ferinject in pregnant women.
Ask your doctor for advice before you are given Ferinject.
For more information, consult your doctor or your pharmacist.
